Position in VRTX
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$102,876,756
+$9,035,482 QoQ
Shares Held
207,108
-1.4% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#112
of 1,735 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2022CallValue
$289,540
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $137,698,050 across 19 Biotechnology names. VRTX ranks #1 (74.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
207,108 | $102,876,756 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
283,960 | $22,515,188 | |
| 3 | CGTX |
Cognition Therapeutics Inc
|
4,259,511 | $4,898,437 | |
| 4 | GMAB |
Genmab A/S
|
42,544 | $1,168,683 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
72,370 | $977,718 | |
| 6 | ARGX |
Argenx SE
|
929 | $861,898 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
3,190 | $768,694 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
19,500 | $651,105 |
All Filings in VRTX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,876,756 | 207,108 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $93,841,274 | 210,152 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $95,920,548 | 211,577 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $85,097,105 | 217,284 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $100,697,116 | 226,184 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $109,234,794 | 225,310 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $87,815,983 | 218,068 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $102,182,261 | 219,709 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $103,833,198 | 221,525 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $91,456,825 | 218,791 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $89,205,749 | 219,238 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $40,153,190 | 115,469 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $40,790,240 | 115,911 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $4,519,364 | 14,344 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $4,256,039 | 14,738 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $4,221,782 | 14,581 | Shares | Sole | 2022-10-11 | |
| 2022-09-30 | $289,540 | 1,000 | Call | Sole | 2022-10-11 | |
| 2022-06-30 | $422,685 | 1,500 | Call | Sole | 2022-07-18 | |
| 2022-06-30 | $5,879,548 | 20,865 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $469,746 | 1,800 | Call | Sole | 2022-05-02 | |
| 2022-03-31 | $5,811,801 | 22,270 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $4,549,453 | 20,717 | Shares | Sole | 2022-02-10 | |
| 2021-12-31 | $395,280 | 1,800 | Call | Sole | 2022-02-10 | |
| 2021-09-30 | $3,337,394 | 18,399 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $3,453,317 | 17,127 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $30,435,730 | 141,634 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $31,441,728 | 133,036 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $520,565 | 1,913 | Shares | Sole | 2020-10-15 | |
| No filing history on record for this holder in this stock. | ||||||